Cryptococcal meningitis in non-HIV-infected patients

QJM: An International Journal of Medicine

Volumn 93, Issue 4, 2000, Pages 245-251

  Shih, C C ^a   Chen, Y C ^a   Chang, S C ^a   Luh, K T ^a   Hsieh, W C ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FUNGUS ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL FEATURE; DISEASE SEVERITY; FEVER; FUNGAL MENINGITIS; HEADACHE; HUMAN; INFLAMMATION; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RECURRENCE RISK; T LYMPHOCYTE; TAIWAN; VOMITING;

EID: 0034113897     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/93.4.245     Document Type: Article

References (28)

1. Butler WT, Alling DW, Spickard AS, Utz JP. Diagnostic and prognostic value of clinical and laboratory findings in cryptococcal meningitis. N Engt J Med 1964; 270:59-67.
2. Bennett JE, Dismukes WE, Duma RV, Medoff G, Sande MA, Gallis H, Leonard J, Fields BT, Bradshaw M, Haywood H, McGee ZA, Cate TR, Cobbs CG, Warner JF, Alling DW. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N Engl J Med 1979; 301:126-31.
3. Powderly WG, Saag MS, Cloud GA, Robinson P, Meyer RD, Jacobson JM, et al. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 1992; 326:793-8.
4. KartaLija M, Kaye K, Tureen JH, Liu Q, Tauber MG, Elliot BR, Sande MA. Treatment of experimental cryptococcal meningitis with fluconazole: impact of dose and addition of flucytosine on mycologic and pathophysiologic outcome. J Infect Dis 1996; 173:1261-21.
5. Van Der Horst CM, Saag MS, Cloud GA, Hamill RJ, Graybill JR, Sobel JD, Johnson PC, Tuazon CU, Kerkering T, Moskovitz BL, Powderly WG, Dismukes WE. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl J Med 1997; 337:15-21.
6. Dismukes WE, Cloud G, Gallis HA, Kerkering TM, Medoff G, Carven PC, Kaplowitz LG, Fisher JF, Gregg CR, Bowles CA, Shadomy S, Stamm AM, Diasio RB, Kauman L, Soong SJ, Blackwelder WC, the National Institute of Allergy and Infectious Diseases Mycoses Study Group. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med 1987; 317:334-41.
7. Rozenbaum R, Goncalves AJR. Clinical epidemiological study of 171 cases of cryptococcosis. Clin Infect Dis 1994; 18:369-80.
8. Mitchell DH, Sorrell TC, Allworth AM, Heath CH, McGregor AR, Papanaoum K, Richards MJ, Gottlieb T. Cryptococcal disease of the CNS in immunocompetent host: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis 1995; 20:611-16.
9. Speed B, Dunt D. Clinical and host difference between infections with two varieties of Cryptococcus neoformans. Clin Infect Dis 1995; 21:28-34.
10. Dromer F, Mathoulin S, Dupont B, Brugiere O, Letenneur L, the French Cryptococcosis Study Group. Comparison of the efficacy of amphotericin B and fluconazole in the treatment of cryptococcosis in human immunodeficiency virus-negative patients: retrospective analysis of 83 cases. Clin Infect Dis 1996; 22(Suppl 2):S1154-60.
11. Tjia TL, Yeow YK, Tan CB. Cryptococcal meningitis. J Neurol Neurosurg Psychiatry 1985; 48:853-8.
12. Richardson PM, Mohandas A, Arumugasamy N. Cerebral cryptococcosis in Malaysia. J Neurol Neurosurg Psychiatry 1976; 39:330-7.
13. Lalloo D, Fisher D, Naraqi A, Laurenson I, Temu P, Sinha A, Saweri A, Mavo B. Cryptococcal meningitis (C. neoformans var. gattii) leading to blindness in previously healthy Melanesian adults in Papua New Guinea. Q J Med 1994; 87:343-9.
14. Seaton RA, Naraqi S, Wembri JP, Warrell DA. Predictors of outcome in Cryptococcus neoformans var. gattii meningitis. Q J Med 1996; 89:423-8.
15. Schmutzhard E, Boongird P, Gerstenbrand F, Jitpimolmard S, Ponglikitmongkol S, Vejjajiva A. Is cryptococcal meningoencephalitis in the tropics a distinct entity? A retrospective study from Thailand. Trop Geogr Med 1990; 42:133-9.
16. Stuck AE, Minder CE, Frey FJ. Risk of infectious complication in patients taking glucocorticoids. Rev Infect Dis 1989; 11:954-63.
17. Fauci JF, Dale DC, Balow JE. Glucocorticoid therapy: mechanism of action and clinical consideration. Ann Intern Med 1976; 84:304-15.
18. Diamond RD, Bennett JE. Prognostic factors in cryptococcal meningitis: a study in 111 cases. Ann Intern Med 1974; 80:176-81.
19. Saag MS, Powderly WG, Cloud GA, Robinson P, Grieco MH, Sharkey PK, Thompson SE, Sugar AM, Tuazon CU, Fisher JF, et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group N Engl J Med 1992; 326:83-9.
20. Bennett JE, Kwon-Chung KJ, Howard DH. Epidemiologic differences among serotypes of Cryptococcus neoformans. Am J Epidemiol 1977; 105:582-6.
21. Ellis DH, Pfeiffer TJ. Natural habitat of Cryptococcus neoformans var. gattii. J Clin Microbiol 1990; 28:1642-4.
22. Kwon-Chung KJ, Bennett JE. Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotype A and D) and Cryptococcus neoformans var. gattii (serotype B and C). J Clin Microbiol 1982; 15:535-7.
23. Slain IE, HUD NJ. New medium for differentiation of Cryptococcus neoformans stereotype pairs. J Clin Microbiol 1982; 15:169-71.
24. Ikeda R, Shinoda T, Fukuzawa Y, Kaufman L. Antigenic characterization of Cryptococcus neoformans serotype and its application to serotyping of clinical isolates. J Clin Microbiol 1982; 16:22-9.
25. Sarosi GA, Parker JD, Doto IL, Tosh FE. Amphotericin B in cryptococcal meningitis: long-term results of treatment. Ann Intern Med 1969; 71:1079-87.
26. De Wytt CN, Dickson PL, Holt GW. Cryptococcal meningitis: a review of 32 years experience. J Neurol Sci 1982; 53:283-92.
27. Moosa MYS, Coovadia YM. Cryptococcal meningitis in Durban, south Africa: a comparison of clinical feature, laboratory findings, and outcome for human immunodeficiency virus (HIV)-positive and HIV negative patients. Clin Infect Dis 1997; 24:131-4.
28. Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS - 100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995; 8:515-48.